SE9800729L - Ny topikal formulering I - Google Patents

Ny topikal formulering I

Info

Publication number
SE9800729L
SE9800729L SE9800729A SE9800729A SE9800729L SE 9800729 L SE9800729 L SE 9800729L SE 9800729 A SE9800729 A SE 9800729A SE 9800729 A SE9800729 A SE 9800729A SE 9800729 L SE9800729 L SE 9800729L
Authority
SE
Sweden
Prior art keywords
topical formulation
new topical
emulsifier
new
carrier
Prior art date
Application number
SE9800729A
Other languages
English (en)
Swedish (sv)
Other versions
SE9800729D0 (sv
Inventor
Anders Carlsson
Jenny Ek
Bengt Hersloef
Goeran Nilsson
Original Assignee
Scotia Lipidteknik Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20410443&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9800729(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scotia Lipidteknik Ab filed Critical Scotia Lipidteknik Ab
Priority to SE9800729A priority Critical patent/SE9800729L/xx
Publication of SE9800729D0 publication Critical patent/SE9800729D0/xx
Priority to DE69912760T priority patent/DE69912760T2/de
Priority to NZ506756A priority patent/NZ506756A/en
Priority to PCT/SE1999/000347 priority patent/WO1999044585A1/en
Priority to PT99913784T priority patent/PT1069886E/pt
Priority to AT99913784T priority patent/ATE253895T1/de
Priority to JP2000534188A priority patent/JP2002505272A/ja
Priority to DK99913784T priority patent/DK1069886T3/da
Priority to ES99913784T priority patent/ES2211062T3/es
Priority to EP99913784A priority patent/EP1069886B1/en
Priority to AU31778/99A priority patent/AU750526B2/en
Priority to CA002322850A priority patent/CA2322850A1/en
Publication of SE9800729L publication Critical patent/SE9800729L/xx
Priority to US10/976,127 priority patent/US20050063930A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9800729A 1998-03-06 1998-03-06 Ny topikal formulering I SE9800729L (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE9800729A SE9800729L (sv) 1998-03-06 1998-03-06 Ny topikal formulering I
CA002322850A CA2322850A1 (en) 1998-03-06 1999-03-08 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance
AU31778/99A AU750526B2 (en) 1998-03-06 1999-03-08 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance
AT99913784T ATE253895T1 (de) 1998-03-06 1999-03-08 Verwendung von topischen formulierungen des öl-in-wasser typs, enthaltend galaktolipid material als emulsionsmittel, um eine länger anhaltende wirkung eines darin enthaltenen aktiven wirkstoffs zu vermitteln
NZ506756A NZ506756A (en) 1998-03-06 1999-03-08 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance
PCT/SE1999/000347 WO1999044585A1 (en) 1998-03-06 1999-03-08 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance
PT99913784T PT1069886E (pt) 1998-03-06 1999-03-08 Formulacoes topica do tipo oleo-em-agua compreendendo um material galactolipidico como emulsionante com um efeito prolongado de uma substancia activa incorporada
DE69912760T DE69912760T2 (de) 1998-03-06 1999-03-08 Verwendung von topischen formulierungen des öl-in-wasser typs, enthaltend galaktolipid material als emulsionsmittel, um eine länger anhaltende wirkung eines darin enthaltenen aktiven wirkstoffs zu vermitteln
JP2000534188A JP2002505272A (ja) 1998-03-06 1999-03-08 乳化剤としてガラクト脂質物質からなり、導入された活性物質の持続作用を有する水中油型局所用組成物
DK99913784T DK1069886T3 (da) 1998-03-06 1999-03-08 Anvendelse af en topisk formulering af typen olie-i-vand omfattende galactolipidmateriale som emulgator til tilvejebringelse af en forlænget virkning af et inkorporeret aktivt stof
ES99913784T ES2211062T3 (es) 1998-03-06 1999-03-08 Utilizacion de una formulacion topica del tipo de emulsion de aceite en agua, que comprende como emulsionante un material galactolipidico, para proporcionar un efecto prolongado de una sustancia activa incorporada.
EP99913784A EP1069886B1 (en) 1998-03-06 1999-03-08 Use of a topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, for providing a prolonged effect of an incorporated active substance
US10/976,127 US20050063930A1 (en) 1998-03-06 2004-10-29 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9800729A SE9800729L (sv) 1998-03-06 1998-03-06 Ny topikal formulering I

Publications (2)

Publication Number Publication Date
SE9800729D0 SE9800729D0 (sv) 1998-03-06
SE9800729L true SE9800729L (sv) 1999-09-07

Family

ID=20410443

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9800729A SE9800729L (sv) 1998-03-06 1998-03-06 Ny topikal formulering I

Country Status (12)

Country Link
EP (1) EP1069886B1 (https=)
JP (1) JP2002505272A (https=)
AT (1) ATE253895T1 (https=)
AU (1) AU750526B2 (https=)
CA (1) CA2322850A1 (https=)
DE (1) DE69912760T2 (https=)
DK (1) DK1069886T3 (https=)
ES (1) ES2211062T3 (https=)
NZ (1) NZ506756A (https=)
PT (1) PT1069886E (https=)
SE (1) SE9800729L (https=)
WO (1) WO1999044585A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2304906A1 (en) 2000-04-07 2001-10-07 1411198 Ontario Limited 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
EP1151745A1 (fr) * 2000-05-05 2001-11-07 L'oreal Composition sous forme d'émulsion eau-dans-huile et ses utilisations cosmétiques
US20020165286A1 (en) * 2000-12-08 2002-11-07 Hanne Hedeman Dermal anti-inflammatory composition
AU2003279622A1 (en) 2002-06-28 2004-01-19 Nitromed, Inc. Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
KR101243526B1 (ko) * 2004-08-31 2013-03-20 스티펠 리서치 오스트레일리아 피티와이 리미티드 마이크로에멀젼 및 서브마이크론 에멀젼 방법 및 조성물
US8449867B2 (en) 2004-08-31 2013-05-28 Stiefel Research Australia Pty Ltd Microemulsion and sub-micron emulsion process and compositions
PL1879466T5 (pl) * 2005-03-04 2016-07-29 Dsm Ip Assets Bv Spożywcza cząsteczkowa kompozycja lipidowa
DE102005023640A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden und einem oder mehreren partiell neutralisierten Ester von Monoglyceriden und / oder Diglyceriden gesättigter Fettsäuren mit Zitronensäure
US20080260816A1 (en) * 2005-09-16 2008-10-23 Bengt Herslof Particulate Lipid Pharmaceutical Composition
EP2455382B1 (en) 2005-12-13 2016-10-26 Incyte Holdings Corporation Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
WO2008084253A1 (en) * 2007-01-12 2008-07-17 Lipopeptide Ab Use of a galactolipid for wound and ulcer healing
US20100136124A1 (en) * 2007-04-20 2010-06-03 University Of South Australia Nanoparticle-coated capsule formulation for dermal drug delivery
PT2496263T (pt) 2009-11-03 2022-03-28 Lipidor Ab Composição que forma uma camada lipídica para administração sobre uma superfície de um organismo vivo
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
SG10201801069QA (en) 2013-08-07 2018-03-28 Incyte Corp Sustained release dosage forms for a jak1 inhibitor
JP2017529334A (ja) * 2014-08-27 2017-10-05 アッヴィ・インコーポレイテッド 局所製剤
US11617724B2 (en) 2015-05-21 2023-04-04 Dermavant Sciences GmbH Topical pharmaceutical compositions
CN107666902B (zh) 2015-05-21 2021-09-21 德玛万科学有限责任公司 局部药物组合物
CN108282998B (zh) 2015-06-18 2021-07-06 凡利亚药品北美公司 用于治疗银屑病的包含皮质类固醇和类视黄醇的局部组合物
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597118A (ja) * 1982-06-16 1984-01-14 ユニリ−バ−・ナ−ムロ−ゼ・ベンノ−トシヤ−プ 化粧用組成物
JPS649908A (en) * 1987-07-02 1989-01-13 Kao Corp Cosmetic, cosmetic set and make-up method
JPH0374316A (ja) * 1989-08-11 1991-03-28 Kanebo Ltd 保湿剤
JPH0818948B2 (ja) * 1990-08-31 1996-02-28 花王株式会社 水性化粧料及びその製造法
JPH0543465A (ja) * 1991-08-08 1993-02-23 Mitsubishi Kasei Corp コルチコステロイド含有ローシヨン剤
JPH069365A (ja) * 1992-06-25 1994-01-18 Kanebo Ltd 皮膚化粧料
PL176941B1 (pl) * 1993-03-12 1999-08-31 Axys Pharmaceuticals Nowe peptydy i środek farmaceutyczny do leczenia immunologicznych stanów zapalnych
FR2710854B1 (fr) * 1993-10-08 1995-12-01 Oreal Emulsion huile-dans-eau utilisable pour l'obtention d'une crème.
BR9506681A (pt) * 1994-02-04 1997-11-18 Scotia Lipidteknik Ab Emulsão oleo em água e composição farmacêutica
SE9402453D0 (sv) * 1994-07-12 1994-07-12 Astra Ab New pharmaceutical preparation
JPH08165244A (ja) * 1994-10-12 1996-06-25 Taisho Pharmaceut Co Ltd 皮膚疾患治療剤
ZA96525B (en) * 1995-02-06 1996-08-06 Astra Ab Novel pharmaceutical compositions
SE504664C2 (sv) * 1995-09-22 1997-03-24 Scotia Lipidteknik Ab Sätt att framställa fraktionerad olja, oljan, dess användning samt emulsionskomposition innehållande oljan
JP3326059B2 (ja) * 1995-10-05 2002-09-17 カネボウ株式会社 皮膚化粧料

Also Published As

Publication number Publication date
JP2002505272A (ja) 2002-02-19
ES2211062T3 (es) 2004-07-01
WO1999044585A1 (en) 1999-09-10
AU750526B2 (en) 2002-07-18
EP1069886A1 (en) 2001-01-24
DE69912760D1 (de) 2003-12-18
SE9800729D0 (sv) 1998-03-06
DE69912760T2 (de) 2004-09-30
PT1069886E (pt) 2004-04-30
EP1069886B1 (en) 2003-11-12
CA2322850A1 (en) 1999-09-10
ATE253895T1 (de) 2003-11-15
DK1069886T3 (da) 2004-03-22
NZ506756A (en) 2003-10-31
AU3177899A (en) 1999-09-20

Similar Documents

Publication Publication Date Title
SE9800729L (sv) Ny topikal formulering I
DK0892638T3 (da) Liposombaseret, topisk vitamin D-præparat
ATE286718T1 (de) Temperatursensitive liposomale formulierung
BR0314354A (pt) Formação para gentes lipofìlicos
CO4940390A1 (es) Composicion liquida de limpieza antimicrobiana que comprende un activo antimicrobiano, un surfactante, agentes y un esta- bilizador
BR0009893A (pt) Composição de cuidado com a pele; e uso de uma composição de cuidado com a pele
FR2784294B1 (fr) Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique
ATE269047T1 (de) Emulgatorfreie und bornitrid enthaltende feindisperse systeme vom typ öl-in-wasser und wasser-in-öl
BR0108738A (pt) Formulações anestésicas
ATE321534T1 (de) Verbesserte liposomale formulierung
BR9806268A (pt) Composições contendo um antifúngico e um fosfolipìdeo
BR0013968B1 (pt) composicão estruturante de produto para formulações de cuidados pessoais.
SE9800730L (sv) Ny topikal formulering II
ATE245900T1 (de) Pour-on formulierung enthaltend polymerische material, glykole und glyzeriden
TR199903271T2 (en) Tokoferol ile karl�la�t�r�lan soluma i�in prolipozom tozlar�.
DE59800863D1 (de) Transdermale, orale und intravenöse zubereitungen von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon
HUP0202823A2 (en) Topical organic ectoparasiticidal formulations
EP1269978A3 (de) Verwendung von Bis-Resorcinyltriazinderivaten in kosmetischen oder dermatologischen Zubereitungen
DK0647129T3 (da) Præparat til topisk anvendelse
DE59101404D1 (de) Topische Präparate.
DE60001096D1 (de) Lipidmembran zusammensetzungen
DE59900473D1 (de) Wirkstoffkombinationen aus vitamin a- derivate und ubi- oder plastochinonen enthaltende hautpflegmittel
ATE263576T1 (de) Prostaglandine und benzylalcohol enthaltende lösung
DE69906116D1 (de) Vitaminzusammensetzung zur topischen anwendung
UY26510A1 (es) " biblioteca de sustancias, procedimiento para su preparación y el uso de esta biblioteca de sustancias para la investigación de sustancias activas."

Legal Events

Date Code Title Description
NAV Patent application has lapsed